Valeo Pharma Stock Price To Book
| VPHIF Stock | USD 0.05 0.00 0.00% |
Valeo Pharma fundamentals help investors to digest information that contributes to Valeo Pharma's financial success or failures. It also enables traders to predict the movement of Valeo Pink Sheet. The fundamental analysis module provides a way to measure Valeo Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Valeo Pharma pink sheet.
Valeo |
Valeo Pharma Company Price To Book Analysis
Valeo Pharma's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Valeo Pharma Price To Book | 66.75 X |
Most of Valeo Pharma's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Valeo Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Valeo Pharma has a Price To Book of 66 times. This is 159.92% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to book for all United States stocks is notably lower than that of the firm.
Valeo Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Valeo Pharma's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Valeo Pharma could also be used in its relative valuation, which is a method of valuing Valeo Pharma by comparing valuation metrics of similar companies.Valeo Pharma is currently under evaluation in price to book category among its peers.
Valeo Fundamentals
| Return On Equity | -16.0 | |||
| Return On Asset | -0.26 | |||
| Profit Margin | (0.93) % | |||
| Operating Margin | (0.61) % | |||
| Current Valuation | 57.28 M | |||
| Shares Outstanding | 82.19 M | |||
| Shares Owned By Insiders | 47.72 % | |||
| Price To Book | 66.75 X | |||
| Price To Sales | 2.14 X | |||
| Revenue | 27.75 M | |||
| Gross Profit | 8.52 M | |||
| EBITDA | (19.04 M) | |||
| Net Income | (25.75 M) | |||
| Cash And Equivalents | 27.72 M | |||
| Cash Per Share | 0.34 X | |||
| Total Debt | 59.53 M | |||
| Current Ratio | 2.88 X | |||
| Book Value Per Share | (0.22) X | |||
| Cash Flow From Operations | (28.5 M) | |||
| Earnings Per Share | (0.21) X | |||
| Number Of Employees | 115 | |||
| Beta | 2.47 | |||
| Market Capitalization | 35.68 M | |||
| Total Asset | 58.27 M | |||
| Net Asset | 58.27 M |
About Valeo Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Valeo Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Valeo Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Valeo Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Valeo Pink Sheet
Valeo Pharma financial ratios help investors to determine whether Valeo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valeo with respect to the benefits of owning Valeo Pharma security.